Effect of age on the pharmacokinetics of fimasartan (BR-A-657)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Effect of age on the pharmacokinetics of fimasartan (BR-A-657)

Published:2011-09-28 Issue:11 Volume:7 Page:1337-1344
ISSN:1742-5255
Container-title:Expert Opinion on Drug Metabolism & Toxicology
language:en
Short-container-title:Expert Opinion on Drug Metabolism & Toxicology

Author:

Lee Hae Won,Lim Mi-sun,Seong Sook Jin,Lee Joomi,Park Jeonghyeon,Seo Jeong Ju,Cho Joo-Youn,Yu Kyung-Sang,Yoon Young-Ran

Publisher

Informa Healthcare

Subject

Pharmacology,Toxicology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1517/17425255.2011.618835

Reference22 articles.

1. Global burden of hypertension: analysis of worldwide data

2. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

3. Comparison of Angiotensin II Type 1 Receptor Antagonists in the Treatment of Essential Hypertension

4. The role of the renin-angiotensin system in the development of cardiovascular disease

5. Clinical Pharmacokinetics of Losartan

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Randomized, Double-blind, Active-controlled, Two Parallel-Group, Optional Titration, Multicenter, Phase IIIb Study to Evaluate the Efficacy and Safety of Fimasartan Versus Perindopril Monotherapy With and Without a Diuretic Combination in Elderly Patients With Essential Hypertension;Clinical Therapeutics;2021-10

2. Fimasartan reduces neointimal formation and inflammation after carotid arterial injury in apolipoprotein E knockout mice;Molecular Medicine;2019-07-15

3. Pharmacokinetic and bioequivalence study comparing a fimasartan/rosuvastatin fixed-dose combination with the concomitant administration of fimasartan and rosuvastatin in healthy subjects;Drug Design, Development and Therapy;2018-10

4. Role of cytochrome P450 enzymes in fimasartan metabolism in vitro;Food and Chemical Toxicology;2018-05

5. 24-Hour blood pressure response to lower dose (30 mg) fimasartan in Korean patients with mild to moderate essential hypertension;The Korean Journal of Internal Medicine;2017-11-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3